Evaluation of the hemodynamic performance of small CarboMedics aortic prostheses using dobutamine-stress Doppler echocardiography. 1995

M B Izzat, and I Birdi, and P Wilde, and A J Bryan, and G D Angelini
Department of Cardiac Surgery, University of Bristol, United Kingdom.

BACKGROUND The well-known correlation between prosthetic valve orifice area and transvalvular gradients has raised concerns about the presence of significant residual gradients when the size of the prosthesis that can be implanted is limited by the presence of a small aortic annulus. METHODS Dobutamine-stress Doppler echocardiography was used to evaluate the hemodynamic performance of small CarboMedics aortic prostheses (19 mm and 21 mm) in 18 patients (16 women; mean age, 64 years) who had undergone aortic valve replacement 23.5 +/- 19 months (standard deviation) previously. Dobutamine infusion was started at a rate of 5 micrograms.kg-1.min-2 and increased to 10 and 20 micrograms.kg-1.min-2 at 15-minute intervals. Pulsed and continuous wave Doppler studies were performed at rest and at the end of each stage. Effective orifice area, performance index, and discharge coefficient of both valves were calculated, and peak and mean velocity and pressure drop across the prostheses were measured. RESULTS Heart rate and cardiac output increased by 74% and 94%, respectively, and mean arterial blood pressure decreased by 9% at maximum stress. Effective orifice area, discharge coefficient, and performance index were comparable in both valve sizes at rest and maximum stress. Also, there was no significant difference in mean transvalvular pressure drop (gradient) for 19-mm and 21-mm prostheses at rest (8.1 +/- 8.4 and 4.8 +/- 3.8 mm Hg) or maximum stress (15.1 +/- 14.2 and 8.8 +/- 5.8 mm Hg, respectively). No significant correlation could be demonstrated between transvalvular pressure drop and patient's body surface area. CONCLUSIONS These data show that 19-mm and 21-mm CarboMedics aortic prostheses exhibit equally favorable hemodynamic performance with minimal pressure gradient, both at rest and under stress conditions.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011474 Prosthesis Design The plan and delineation of prostheses in general or a specific prosthesis. Design, Prosthesis,Designs, Prosthesis,Prosthesis Designs
D004280 Dobutamine A catecholamine derivative with specificity for BETA-1 ADRENERGIC RECEPTORS. It is commonly used as a cardiotonic agent after CARDIAC SURGERY and during DOBUTAMINE STRESS ECHOCARDIOGRAPHY. Dobucor,Dobuject,Dobutamin Fresenius,Dobutamin Hexal,Dobutamin Solvay,Dobutamin-ratiopharm,Dobutamina Inibsa,Dobutamina Rovi,Dobutamine (+)-Isomer,Dobutamine Hydrobromide,Dobutamine Hydrochloride,Dobutamine Lactobionate,Dobutamine Phosphate (1:1) Salt, (-)-Isomer,Dobutamine Tartrate,Dobutamine Tartrate (1:1), (R-(R*,R*))-Isomer,Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer,Dobutamine, (-)-Isomer,Dobutamine, Phosphate (1:1) Salt (+)-Isomer,Dobutrex,Lilly 81929,Oxiken,Posiject,Dobutamin ratiopharm,Hydrobromide, Dobutamine,Hydrochloride, Dobutamine,Lactobionate, Dobutamine,Tartrate, Dobutamine
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D006350 Heart Valve Prosthesis A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material. Prosthesis, Heart Valve,Cardiac Valve Prosthesis,Cardiac Valve Prostheses,Heart Valve Prostheses,Prostheses, Cardiac Valve,Prostheses, Heart Valve,Prosthesis, Cardiac Valve,Valve Prostheses, Cardiac,Valve Prostheses, Heart,Valve Prosthesis, Cardiac,Valve Prosthesis, Heart
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M B Izzat, and I Birdi, and P Wilde, and A J Bryan, and G D Angelini
July 2001, The Annals of thoracic surgery,
M B Izzat, and I Birdi, and P Wilde, and A J Bryan, and G D Angelini
November 2005, The Journal of heart valve disease,
M B Izzat, and I Birdi, and P Wilde, and A J Bryan, and G D Angelini
January 2005, Angiology,
M B Izzat, and I Birdi, and P Wilde, and A J Bryan, and G D Angelini
November 1997, The Journal of heart valve disease,
M B Izzat, and I Birdi, and P Wilde, and A J Bryan, and G D Angelini
December 1997, Angiology,
M B Izzat, and I Birdi, and P Wilde, and A J Bryan, and G D Angelini
March 1988, Cardiologia (Rome, Italy),
M B Izzat, and I Birdi, and P Wilde, and A J Bryan, and G D Angelini
May 2010, International journal of cardiology,
M B Izzat, and I Birdi, and P Wilde, and A J Bryan, and G D Angelini
January 2013, Heart (British Cardiac Society),
M B Izzat, and I Birdi, and P Wilde, and A J Bryan, and G D Angelini
May 1997, The Journal of heart valve disease,
M B Izzat, and I Birdi, and P Wilde, and A J Bryan, and G D Angelini
October 2001, Seminars in thoracic and cardiovascular surgery,
Copied contents to your clipboard!